Novartis files new Hepatitis B treatment in Europe
February 28, 2006Sales and Marketing
Novartis has filed its new hepatitis B treatment telbivudine in the European Union, and says it represents a potential new …
ABPI chief calls for ‘new rules of engagement’
February 23, 2006Sales and Marketing
UK pharmaceutical industry leader Richard Barker has called for a fundamental rethink in the way the industry and the NHS …
Gene silencing technology to be used in war against bird flu
February 23, 2006Sales and Marketing
Cutting edge technology will be used develop new drugs to treat dangerous strains of influenza, including the threat of a …
Wyeth to open clinical trial ‘Super Centres’
February 23, 2006Research and Development
Wyeth has unveiled plans to streamline its drug development operations by opening a network of clinical trial 'Super Centres' around …
Pfizer’s new blood infection drug Eraxis approved
February 23, 2006Research and Development
Eraxis, a new treatment for potentially life-threatening fungal infections has been approved in the US.Pfizer's new antifungal is licensed to …
Sanofi’s wonder drug in limbo after regulator’s rejection
February 23, 2006Sales and Marketing
The future of Sanofi-Aventis' Acomplia is in serious doubt after regulators demanded more data for its use in weight loss, …
Pegasys recommended as front line hepatitis B treatment
February 23, 2006Sales and Marketing
Roche's Pegasys is set to be used more widely in England and Wales to treat hepatitis B following the release …
Tysabri trials restart after safety scare
February 20, 2006Research and Development
Clinical trials of Tysabri, the troubled multiple sclerosis treatment, are to begin again in the US after the FDA gave …
Avastin trial recruitment suspended after patient deaths
February 16, 2006Research and Development
Roche has stopped recruiting colon cancer patients who have undergone surgery to a trial of Avastin after four suddenly died.The …
WHO calls for action on counterfeits
February 16, 2006Manufacturing and Production
The World Health Organisation has called for 'immediate concrete' action against counterfeit medicines, which it says pose serious and sometimes …
Woman loses Herceptin court case
February 16, 2006Breast cancer patient Ann Marie Rogers has lost her court battle to be prescribed Herceptin on the NHS, in what …
Merck files novel diabetes drug Januvia
February 16, 2006Sales and Marketing
Merck has filed an innovative new diabetes treatment with the US regulator, and hopes the drug could be one of …
Working with NHS priorities
February 16, 2006Patients, health professionals and even some politicians have said it, now chief medical officer Nigel Crisp has confirmed it in …
Safety scare spells the end for Exanta
February 15, 2006Sales and Marketing
AstraZeneca is to abandon its novel anti-blood clotting drug Exanta after concerns emerged about its long-term safety.Just two years ago, …
Wyeth joins search for promising TLR drugs
February 15, 2006Research and Development
A new collaboration between Wyeth and an Irish biotech company is to investigate the potential of 'toll like receptors', which …
Reaching new heights in branding
February 15, 2006Sales and Marketing
The pharma industry has come a long way from the days when it believed that products were all about safety …
Talman and Crozier launch new PR agency
February 14, 2006Medical Communications
Two senior healthcare PR executives have launched Just:: a new agency which they say will redefine the traditional client/agency relationship.Emma …
Abbott suspended from ABPI over sleaze
February 10, 2006Sales and Marketing ethics
All expenses paid trips for doctors to see greyhound racing, visits to Wimbledon centre court and even a lap dancing …
More Tamiflu released for UK areas hit by seasonal flu
February 10, 2006Sales and Marketing
Extra supplies of anti-viral treatment Tamiflu are to be made available in areas of the UK suffering from high levels …
GSK looks ahead to surge of products in 2006
February 10, 2006Sales and Marketing
GlaxoSmithKline has unveiled strong growth in sales and earnings in 2005, and is preparing for a series of key filings, …
